We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOK icon
901
Stoke Therapeutics
STOK
$2.11B
$31K ﹤0.01%
815
-15
-2% -$854
SUPN icon
902
Supernus Pharmaceuticals
SUPN
$2.77B
$31K ﹤0.01%
1,190
-20
-2% -$559
ZS icon
903
Zscaler
ZS
$27.3B
$31K ﹤0.01%
183
+28
+18% +$5.56K
GEN icon
904
Gen Digital
GEN
$17.5B
$30K ﹤0.01%
1,455
+236
+19% +$4.95K
WPC icon
905
W.P. Carey
WPC
$16.4B
$30K ﹤0.01%
437
+65
+17% +$4.36K
GSKY
906
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$30K ﹤0.01%
4,929
+3,286
+200% +$18.8K
TBPH icon
907
Theravance Biopharma
TBPH
$877M
$29K ﹤0.01%
1,460
-5
-0.3% -$95
YMAB
908
DELISTED
Y-mAbs Therapeutics
YMAB
$29K ﹤0.01%
980
+50
+5% +$2.05K
ALLE icon
909
Allegion
ALLE
$14.4B
$28K ﹤0.01%
225
+32
+17% +$3.7K
LNC icon
910
Lincoln National
LNC
$8.81B
$28K ﹤0.01%
457
+72
+19% +$3.98K
MPT
911
Medical Properties Trust
MPT
$2.81B
$28K ﹤0.01%
1,320
+208
+19% +$4.47K
FMTX
912
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$28K ﹤0.01%
1,010
+65
+7% +$2.35K
OPTU
913
Optimum Communications Inc
OPTU
$301M
$27K ﹤0.01%
837
+128
+18% +$4.46K
FDS icon
914
Factset
FDS
$10.2B
$27K ﹤0.01%
89
+11
+14% +$3.48K
INVA icon
915
Innoviva
INVA
$1.48B
$27K ﹤0.01%
2,295
-80
-3% -$967
ITOS
916
DELISTED
iTeos Therapeutics
ITOS
$27K ﹤0.01%
790
-15
-2% -$542
JKHY icon
917
Jack Henry & Associates
JKHY
$11.1B
$27K ﹤0.01%
183
+24
+15% +$3.66K
LKQ icon
918
LKQ Corp
LKQ
$6.29B
$27K ﹤0.01%
655
+104
+19% +$4.09K
NRIX icon
919
Nurix Therapeutics
NRIX
$2.65B
$27K ﹤0.01%
885
-5
-0.6% -$189
OCUL icon
920
Ocular Therapeutix
OCUL
$2.02B
$27K ﹤0.01%
1,700
+60
+4% +$1.16K
DAY
921
DELISTED
Dayforce
DAY
$27K ﹤0.01%
326
+51
+19% +$4.76K
BKI
922
DELISTED
Black Knight, Inc. Common Stock
BKI
$27K ﹤0.01%
376
+56
+18% +$4.51K
TBIO
923
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$27K ﹤0.01%
1,680
-40
-2% -$911
ATRA icon
924
Atara Biotherapeutics
ATRA
$76.1M
$26K ﹤0.01%
75
+4
+6% +$1.77K
BRO icon
925
Brown & Brown
BRO
$23.9B
$26K ﹤0.01%
585
+88
+18% +$4.04K

Similar funds

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.